Session One: Project ECHO - Evolving Role of Bispecific Antibodies as Cancer Therapy (Overview)

You must have an ACCC account in order to register for Session One: Project ECHO - Evolving Role of Bispecific Antibodies as Cancer Therapy (Overview).

If You DO NOT Have An ACCC Account:

  • To start, click the green “Register” button in the upper right corner of this page. You will be directed to “Your Cart.” Click the green “Log In” button near the top of the page.
    • ACCC members: Click “Reset Password” to update your login information. When your password is updated, you will be redirected to the “My Profile” page, where you can view and update your information.
    • OSS at ACCC Members: Please use your state society login credentials.
    • Non-members: Click “Create Account.” Once your password is created, you will be redirected to the "My Profile" page, where you can view and update your information. Click “Change” to add your Areas of Concentration, then save your information.
  • Click “eLearning” at the top of your profile page to go back to the ACCC eLearning portal. In the box on the left side of the screen, click on the “Cart” link.
  • The green box in the upper right corner of this page will indicate “You are registered!” for this course. Congratulations!

If You Have An ACCC Account:

  • Please click the orange “Log In” button on the left side of this screen. You will be taken to the main login page that displays your email and password. Click the “Log in” button.
  • You will be automatically redirected back to this webinar page, and the green box in the upper right corner will say that “You are registered!” for this course. Congratulations!

PRO TIP: If you save your ACCC password to your computer and remain logged in, you can register for additional webinars and courses in a matter of seconds—with just one click!

For the best registration and viewing experience, please use Chrome, Edge, or Safari web browsers. Internet Explorer Users may experience difficulties accessing the webinar.

Once you complete your registration, you will receive an email from ACCC eLearning, which contains information on how to access this Session One: Project ECHO - Evolving Role of Bispecific Antibodies as Cancer Therapy (Overview). For assistance with registration or if you do not receive an email, please contact registration@accc-cancer.org.

istration@accc-cancer.org.

Release date: May 23, 2024

Expiration date: May 23, 2025

Bispecific antibodies (BsAbs), an emerging class of novel immunotherapy agents, have great therapeutic potential; however, they also present barriers to care including unique and serious treatment-related toxicities that can preclude their widespread use in the community practice setting. To provide optimal care to patients being treated with BsAbs, clinicians must understand the unique pharmacology and potential clinical and logistical challenges of these agents. Successful administration of BsAbs requires competence and effective collaboration among multidisciplinary providers on the cancer care team.  

Target Audience:  

The target audience for this initiative includes oncologists, oncology advanced practice providers (nurse practitioners, physician assistants), oncology pharmacists, oncology nurses, and other healthcare professionals (HCPs) involved in treating patients with cancer immunotherapies.

Learning Objectives: 

At the end of this educational activity, participants should be able to: 

  • Address barriers to the awareness, preparedness, adoption and use of BsAbs for the treatment of cancer. 
  • Improve coordination and communication between community hospitals and academic centers to optimize outcomes for patients beings treated with BsAbs. 
  • Review strategies for providing equitable care for underserved patients receiving cancer immunotherapies. 

Accreditation/Designation of Credit 

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Physicians' Education Resource®, LLC and the Association of Cancer Care Centers (ACCC). Physicians' Education Resource®, LLC is accredited by the ACCME to provide continuing medical education for physicians. 

Physicians' Education Resource®, LLC designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Physicians’ Education Resource®, LLC is approved by the California Board of Registered Nursing, Provider #16669, for 1.0 Contact Hours. 

image

Pharmacy Times  Continuing Education is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 1.0 contact hours (0.10 CEU) under the ACPE universal activity number 0290-9999-24-115-H01-P. The activity is available for CE credit through May 23, 2025. 

Acknowledgement of Commercial Support:  

This activity is supported by an educational grant from Genentech. 

Disclosures and Conflict of Interest (COI) Mitigation 

Faculty, Staff, and Planners’ Disclosures 

The following individuals have no relevant financial relationships with ineligible companies to disclose: Molly Kisiel, MSN, FNP-BC, Mary Stanley, LMSW, PMP, and the staff of Physicians’ Education Resource®, LLC. 

Firas El Chaer, MD – Consultant: SPD Oncology, Amgen, CTI Biopharma, AbbVie, MorphoSys, ACCC; Travel Grant: Dava Oncology

Kirollos Hanna, PharmD, BCPS, BCOP, FACC – Consultant: Seagen, Beigene, BMS; Speakers’ Bureau: Seagen, Beigene, Exelixis, BMS

Amelia Hodson, MSN, AG-ACNP – Consultant: Geron

Murali Janakiram, MD, MS – Speaker: Janssen


Firas El Chaer, MD

Assistant Professor, UVA Health

Dr. El Chaer is an Assistant Professor of Medicine who specializes in hematology and oncology. His clinical areas of interest are acute leukemia, chronic leukemia, myelodysplastic syndrome, myeloproliferative disorders, aplastic anemia, clonal hematopoiesis, and blood disorders. His research focuses on improving outcomes for acute leukemia in adults by focusing on targeted therapies and overcoming resistance mechanisms. 

Dr. El Chaer attended medical school at the University of Balamand in Beirut, Lebanon, and completed his internal medicine residency at the Icahn School of Medicine at Mount Sinai, in EnglewoodNew Jersey, where he served as chief resident from 2013 - 2014. He then completed a fellowship in infectious diseases for immune-compromised cancer patients at the combined program of Baylor College of Medicine and MD Anderson Cancer Center in Houston, Texas.  

Dr. El Chaer pursued a fellowship in hematology and oncology with a focus on blood disorders and also completed a built-in fellowship in stem cell transplantation at the University of Maryland School of Medicine, where he served as a chief fellow from 2018 - 2019. 

Kirollos S. Hanna, PharmD, BCPS, BCOP, FACCC

Oncology Pharmacy Manager

M Health Fairview - Maple Grove

Dr. Hanna is board certified by the Board of Pharmacy Specialties in Oncology Pharmacy and Pharmacotherapy. He received his doctorate of pharmacy from Florida A&M University, completed his general residency at St. Thomas Hospital, Nashville, TN and his oncology residency at St. Luke's Mountain States Tumor Institute, Boise, ID. He is currently an Assistant Professor of Pharmacy at the Mayo Clinic College of Medicine and the Oncology Pharmacy Manager at M Health Fairview, Maple Grove.

Dr. Hanna’s research interests are focused on B-cell malignancies and genitourinary cancers. He has published over a dozen peer-reviewed manuscripts in various journals including Pharmacotherapy, AJHP, Drugs, JOPP, AJMC and JHOP. He is also an active member of the Hematology/Oncology Pharmacy Association, Association of Community Cancer Centers, Patient-Centered Outcomes Research Institute, Aplastic Anemia and MDS International Foundation and the American College of Clinical Pharmacy. 

Amelia Hodson, AG-ACNP

UVA Health

Amelia S. Hodson, AG-ACNP, is a board-certified nurse practitioner, who cares for hospitalized patients undergoing stem cell transplant for blood and other cancers.

She began her career at UVA in 2007 as a registered nurse. She has specialized in oncology (cancer) since 2015. She spent three years as a clinical research nurse in malignant hematology (blood disorders) before transitioning to the hospital unit for oncology and stem cell transplant patients.

She earned her RN degree at UVA and her master’s degree in nursing at Maryville University. She is board-certified by the American Nurses Credentialing Center as an adult geriatric acute care nurse practitioner.

Key:

Complete
Failed
Available
Locked
Pretest Questions
4 Questions
Project ECHO Session One
Recorded 03/15/2024  |  65 minutes
Recorded 03/15/2024  |  65 minutes
Credit Claim Instructions
Open to download resource.
Open to download resource.